|
周恩超教授从“毒”论治慢性肾衰竭临床观察
|
Abstract:
目的:探讨苏茵解毒方治疗慢性肾衰竭的临床疗效。方法:选择2019年8月至2021年12月收治的慢性肾功能衰竭患者60例,随机分为对照组和观察组,各30例,对照组予以药用炭治疗,观察组予以苏茵解毒方治疗,比较两组治疗前后的临床疗效。结果:观察组治疗有效率为86.66%,远高于对照组的63.33% (P < 0.05)。治疗后两组的BUN、Scr水平均低于治疗前,观察组明显低于对照组(P < 0.01);eGFR水平高于治疗前,观察组高于对照组(P < 0.05);治疗后中医症状积分较对照组显著降低(P < 0.05)。两组治疗前后均无不良反应。结论:周恩超教授经验方治疗慢性肾衰疗效确切,可显著改善患者肾功能和临床症状,用药安全。
Objective: To investigate the clinical effect of Suyin Jiedu prescription on chronic renal failure. Methods: A total of 60 patients with chronic renal failure admitted from August 2019 to December 2021 were randomly divided into control group (n = 30) and observation group (n = 30). The con-trol group was treated with medicinal charcoal, and the observation group was treated with Suyin Jiedu prescription. The clinical efficacy of the two groups before and after treatment was compared. Results: The effective rate of the observation group was 86.66%, which was much higher than the control group (63.33%, P < 0.05). BUN and Scr levels of the two groups after treatment were lower than before treatment, and the observation group was lower than the control group, eGFR level was higher than before treatment, and the observation group was higher than the control group (P < 0.05). After treatment, TCM symptom score was significantly decreased compared with control group (P < 0.05). There were no adverse reactions before and after treatment in both groups. Con-clusion: Professor Zhou Enchao’s empirical prescription is effective in the treatment of chronic renal failure, can significantly improve renal function and clinical symptoms of patients, and the medica-tion is safe.
[1] | Lv, J.C. and Zhang, L.X. (2019) Prevalence and Disease Burden of Chronic Kidney Disease. In: Liu, B.C., Lan, H.Y. and Lv, L.L., Eds., Renal Fibrosis: Mechanisms and Therapies, Advances in Experimental Medicine and Biology, Vol. 1165, Springer, Singapore, 3-15. https://doi.org/10.1007/978-981-13-8871-2_1 |
[2] | 王善志, 朱永俊, 李国铨, 等. 中国成人慢性肾脏病患病率的Meta分析结果及对比[J]. 中华肾脏病杂志, 2018, 34(8): 579-586. |
[3] | 陈云, 傅文宁, 鲁盈. 中医药对慢性肾脏病5期(非透析)患者治疗优势的临床研究[J]. 世界中医药, 2018, 13(6): 1337-1341. |
[4] | 《中成药治疗优势病种临床应用指南》标准化项目组. 中成药治疗慢性肾脏病3~5期(非透析)临床应用指南(2020年) [J]. 中国中西医结合杂志, 2021, 41(3): 261-272. |
[5] | 俞辉, 彭文, 王云满. 中医药治疗慢性肾脏病疗效优势[J]. 吉林中医药, 2014, 34(6): 637-639. |
[6] | 束洋, 周恩超. “益肾解毒汤”联合中药长程间歇灌肠治疗慢性肾脏病3-4期30例临床研究[J]. 江苏中医药, 2015, 47(11): 29-31. |
[7] | 美国肾脏基金会. NKF-K/DOQI慢性肾脏病贫血治疗的临床实践指南[J]. 中国血液净化杂志, 2007, 8(6): 452. |
[8] | 郑筱萸. 中药新药临床研究指导原则(试行) [M]. 北京: 中国医药科技出版社, 2002: 163-168. |
[9] | 邹燕勤, 孔薇. 慢性肾衰竭中医辨治思路[J]. 江苏中医药, 2018, 50(12): 1-5. |
[10] | 陈香美, 倪兆慧, 刘玉宁, 等. 慢性肾衰竭中西医结合诊疗指南[J]. 中国中西医结合杂志, 2015, 35(9): 1029-1032. |
[11] | 樊威伟, 张大宁. 张大宁从虚、瘀、湿、逆论治慢性肾功能衰竭经验[J]. 中医杂志, 2019, 60(11): 916-918. |
[12] | 沈金峰, 罗富里, 胡芳, 等. 以伏毒新识为核心探讨慢性肾衰竭的病因病机[J]. 中华中医药杂志(原中国医药学报), 2018, 33(12): 5334-5337. |
[13] | 周恩超, 雍晨. 从“肾毒”论治慢性肾脏病[J]. 世界科学技术-中医药现代化, 2021, 23(8): 2802-2806. |
[14] | 姚敏, 周恩超. 从虚与毒论治慢性肾衰竭[J]. 四川中医, 2016, 34(11): 34-36. |
[15] | 尹浩, 周恩超. 周恩超教授从毒论治慢性肾衰竭常用药对介绍[J]. 浙江中医药大学学报, 2016, 40(12): 932-935. |
[16] | 沈金峰, 胡芳, 黄伟, 等. 健脾益肾解毒法对慢性肾脏病患者瘦素、CRP的影响[J]. 中药药理与临床, 2019, 35(3): 165-168. |
[17] | 范伟, 胡路, 柳志猛, 等. 益肾活血利湿解毒法对CKD3-4期患者微炎症状态影响的临床研究[J]. 时珍国医国药, 2018, 29(7): 1669-1672. |
[18] | 杨慧, 马培, 林明宝, 等. 紫苏叶化学成分、抗炎作用及其作用机制研究进展[J]. 中国药理学与毒理学杂志, 2017, 31(3): 279-286. |
[19] | 黄国顺. 基于氧化应激介导MAPK信号通路调控细胞凋亡探讨茵陈对肾损伤的影响以及机制研究[D]: [硕士学位论文]. 南京: 南京中医药大学, 2021. |
[20] | 孙响波, 于妮娜. 六月雪治疗肾脏疾病探源[J]. 中医药导报, 2013, 19(10): 127-128. |